共 50 条
- [43] Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: An INternational VErapamil SR-Trandolapril (INVEST) substudy AMERICAN HEART JOURNAL, 2008, 156 (02) : 241 - 247
- [47] KCNMB1 genotype influences response to verapamil SIR and adverse outcomes in the INternational VErapamil SR/Trandolapril STudy (INVEST) PHARMACOGENETICS AND GENOMICS, 2007, 17 (09): : 719 - 729